A Bioequivalence Study of 3 Formulations of Ondansetron in Healthy Adults (0869-095)(COMPLETED)
Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
This study will assess the bioequivalence of a Merck clinical trial formulation of
ondansetron compared to a U.S. and non-U.S. marketed formulation of ondansetron.